FUSION Trademark

Trademark Overview


On Monday, January 4, 2021, a trademark application was filed for FUSION with the United States Patent and Trademark Office. The USPTO has given the FUSION trademark a serial number of 90447045. The federal status of this trademark filing is REGISTERED as of Tuesday, July 11, 2023. This trademark is owned by Fusion Pharmaceuticals Inc.. The FUSION trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
fusion

General Information


Serial Number90447045
Word MarkFUSION
Filing DateMonday, January 4, 2021
Status700 - REGISTERED
Status DateTuesday, July 11, 2023
Registration Number7108424
Registration DateTuesday, July 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesBiopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 2, 2021
Primary Code005
First Use Anywhere DateMonday, March 27, 2023
First Use In Commerce DateMonday, March 27, 2023

Trademark Owner History


Party NameFusion Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHamilton, Ontario L8P0A6
CA

Party NameFusion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton, Ontario L8P0A6
CA

Party NameFusion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton, Ontario L8P0A6
CA

Trademark Events


Event DateEvent Description
Tuesday, July 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 11, 2023REGISTERED-PRINCIPAL REGISTER
Friday, June 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, May 15, 2023USE AMENDMENT FILED
Tuesday, June 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 15, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 2, 2023SOU EXTENSION 1 FILED
Tuesday, May 2, 2023TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 10, 2022NON-FINAL ACTION E-MAILED
Monday, January 10, 2022NON-FINAL ACTION WRITTEN
Thursday, July 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 22, 2021NON-FINAL ACTION E-MAILED
Thursday, July 22, 2021NON-FINAL ACTION WRITTEN
Monday, July 12, 2021ASSIGNED TO EXAMINER
Friday, April 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2021NEW APPLICATION ENTERED